ANYbotics
Series B in 2024
ANYbotics AG, founded in 2016 and based in Zurich, Switzerland, specializes in developing autonomous, legged robots designed for industrial applications. The company focuses on creating innovative robotic solutions that enhance worker safety and productivity while promoting sustainable industrial practices. ANYbotics' robots are equipped with advanced features such as docking stations, sensing capabilities, and waterproof designs, enabling them to perform various tasks, including routine inspections, asset monitoring, gas detection, and the creation of 3D models. Their technology is particularly beneficial for industries like oil and gas, power, energy, mining, processing, chemicals, transportation, and construction, where complex and hazardous environments require reliable inspection solutions. With a team of over 100 employees, ANYbotics collaborates with global technology leaders to deliver integrated robotic systems that support the operational needs of large asset operators.
NIL Technology ApS
Venture Round in 2024
NIL Technology ApS is a Danish company specializing in the optical design, prototyping, and mass production of optical components. Founded in 2006 and headquartered in Kongens Lyngby, with a branch in Gothenburg, Sweden, the company offers nanostructured masters for a variety of replication technologies, including nanoimprint and UV-replication. NIL Technology develops innovative solutions for sectors such as biotechnology, space applications, consumer product packaging, and renewable energy. Its product range encompasses diffractive optics, microlens arrays, metalenses, optical diffusers, and various optical components used in applications like augmented reality, structured light, and anti-reflection technologies. The company's expertise positions it as a key player in the optical solutions industry.
Fotokite is a company focused on enhancing the capabilities of first responders through its innovative aerial robotics technology. The company has developed a patented system that can be installed on fire trucks and public safety vehicles, allowing firefighters to deploy a drone with the push of a button upon arriving at an incident scene. This drone, capable of reaching heights of up to 45 meters, provides real-time thermal and standard video feeds, enabling teams to quickly assess and visualize the situation without diverting additional personnel for piloting. The Fotokite system operates autonomously, utilizing a tether for power and data transmission, offering over 24 hours of flight time. Users can launch the drone via a tablet, adjusting altitude and camera angle as needed, while the aerial footage can be live-streamed to other responders on-site or back at the fire station. This functionality enhances situational awareness and facilitates more informed resource deployment during emergency events.
Memo Therapeutics
Series C in 2023
Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.
Nagi Bioscience
Series A in 2023
Nagi Bioscience SA is a Swiss company based in Lausanne that specializes in developing and manufacturing an innovative automated testing device utilizing organism-on-chip technology. This device leverages the microscopic worm Caenorhabditis elegans for in vivo testing, enabling pharmaceutical, chemical, and cosmetic companies to assess the toxic and beneficial effects of various substances. By integrating fully automated in vitro handling, culture, and analysis, Nagi Bioscience's platform facilitates toxicity testing, drug discovery, and anthelmintic testing. This approach allows clients to evaluate comprehensive biological responses that can only be observed at the level of the whole organism, thereby transforming traditional testing methodologies.
MedTrace Pharma
Venture Round in 2023
MedTrace Pharma A/S, founded in 2015 and based in Kongens Lyngby, Denmark, specializes in the development of innovative solutions for positron emission tomography (PET) imaging. The company has created an automated system, known as MT-100, which efficiently produces and injects 15O-water, a radioactive tracer essential for enhanced imaging. This system is designed to integrate seamlessly with in-house cyclotrons and PET scanners, significantly increasing the sensitivity of patient analysis while improving throughput by up to four times compared to conventional methods. Additionally, MedTrace Pharma develops the aQuant analytical platform, which aids in interpreting PET scan results, further optimizing the diagnostic process. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace is focused on advancing the capabilities of clinical imaging through automation and innovative technology.
Distran develops advanced acoustic sensing technology to improve safety and environmental performance in industrial settings. Originating from ETH Zurich's Autonomous System Lab, the company creates phased-array ultrasound sensors that spatially filter background noise to locate defects such as leaks or discharges from a safe distance, addressing limits of traditional sensors. The technology enables remote, early defect detection and non-contact monitoring, supporting safer work practices and reduced environmental impact. Distran serves industries including oil and gas, power generation, chemistry, and composite engineering, helping operators monitor machinery, identify issues promptly, and optimize maintenance. By combining directional sensing with robust performance in noisy environments, the company aims to enhance reliability, protect workers, and lower the environmental footprint of industrial operations.
ANYbotics
Series B in 2023
ANYbotics AG, founded in 2016 and based in Zurich, Switzerland, specializes in developing autonomous, legged robots designed for industrial applications. The company focuses on creating innovative robotic solutions that enhance worker safety and productivity while promoting sustainable industrial practices. ANYbotics' robots are equipped with advanced features such as docking stations, sensing capabilities, and waterproof designs, enabling them to perform various tasks, including routine inspections, asset monitoring, gas detection, and the creation of 3D models. Their technology is particularly beneficial for industries like oil and gas, power, energy, mining, processing, chemicals, transportation, and construction, where complex and hazardous environments require reliable inspection solutions. With a team of over 100 employees, ANYbotics collaborates with global technology leaders to deliver integrated robotic systems that support the operational needs of large asset operators.
EcoRobotix
Series B in 2023
EcoRobotix Ltd is a Swiss company founded in 2011, specializing in the development and manufacturing of autonomous farming machines aimed at enhancing agricultural efficiency and sustainability. The company offers an advanced robotic solution designed for the weeding of row crops, meadows, and intercropping cultures. Its flagship product features a sophisticated plant recognition system, utilizing a combination of cameras, GPS RTK, and sensors to accurately identify and locate weeds. This technology allows the robot to apply herbicides with ultra-high precision, significantly reducing chemical usage by 70-95%, which not only lowers costs for farmers but also lessens the environmental impact of conventional farming practices. By improving crop yields while minimizing resource consumption, EcoRobotix positions itself as a key player in promoting sustainable agriculture.
tado°
Venture Round in 2023
tado° GmbH is a technology company based in Munich, Germany, with an additional office in London, United Kingdom. Founded in 2010, it specializes in developing and marketing innovative home climate control systems that enhance the efficiency of heating and cooling in residential and small business environments. The company's products integrate a hardware-software combination that leverages real-time data on resident behavior, weather forecasts, and building characteristics to optimize climate management. tado° sells its solutions through both retail outlets and online platforms, effectively bringing Internet of Things technology to the cleantech market.
Beekeeper
Series C in 2022
Beekeeper is a mobile-first communication platform designed specifically for non-desk employees, facilitating real-time messaging and targeted communication streams across various shifts, locations, and languages. Its application serves as a digital workplace hub, integrating multiple operational systems and communication channels to enhance employee engagement and retention. By automating processes and minimizing dependence on paper, Beekeeper transforms traditional workplace operations, allowing frontline workers to access essential resources such as schedules and paystubs. The platform enables users to communicate instantly, share files, and assign tasks through group chats or predefined streams, all of which can be accessed securely from both desktop and mobile devices. This comprehensive approach empowers clients to improve productivity and effectively connect their teams.
Memo Therapeutics
Series B in 2022
Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.
Fotokite is a company focused on enhancing the capabilities of first responders through its innovative aerial robotics technology. The company has developed a patented system that can be installed on fire trucks and public safety vehicles, allowing firefighters to deploy a drone with the push of a button upon arriving at an incident scene. This drone, capable of reaching heights of up to 45 meters, provides real-time thermal and standard video feeds, enabling teams to quickly assess and visualize the situation without diverting additional personnel for piloting. The Fotokite system operates autonomously, utilizing a tether for power and data transmission, offering over 24 hours of flight time. Users can launch the drone via a tablet, adjusting altitude and camera angle as needed, while the aerial footage can be live-streamed to other responders on-site or back at the fire station. This functionality enhances situational awareness and facilitates more informed resource deployment during emergency events.
Medimaps Group
Venture Round in 2021
Medimaps Group is a developer of medical insights software focused on enhancing the diagnosis and treatment of osteoporosis by assessing bone microarchitecture. The company designs tools that utilize artificial intelligence to analyze imaging data from DXA, X-ray, and projected CT images, enabling healthcare professionals to evaluate bone texture effectively. By employing the trabecular bone score technique, Medimaps Group provides critical quantitative information that aids physicians in selecting optimal treatment options and monitoring patient outcomes. The company is also exploring future applications of its technology in the dental and orthopedic fields, further broadening its impact on patient care.
Beekeeper
Convertible Note in 2021
Beekeeper is a mobile-first communication platform designed specifically for non-desk employees, facilitating real-time messaging and targeted communication streams across various shifts, locations, and languages. Its application serves as a digital workplace hub, integrating multiple operational systems and communication channels to enhance employee engagement and retention. By automating processes and minimizing dependence on paper, Beekeeper transforms traditional workplace operations, allowing frontline workers to access essential resources such as schedules and paystubs. The platform enables users to communicate instantly, share files, and assign tasks through group chats or predefined streams, all of which can be accessed securely from both desktop and mobile devices. This comprehensive approach empowers clients to improve productivity and effectively connect their teams.
Sulzer Schmid
Series B in 2021
Sulzer Schmid is an independent Swiss technology company specializing in advanced solutions for the inspection and analysis of rotor blades. The company has developed a cloud-based platform that provides comprehensive inspection tools and data analytics, enabling windmill operators to monitor the health status of their rotor blades. This platform offers a transparent view of blade conditions across an entire fleet, allowing customers to capture visual data, process images, and generate customizable reports. Through its innovative technology, Sulzer Schmid empowers operators to track damage progression over time, facilitating informed decision-making regarding maintenance and repairs.
MedTrace Pharma
Venture Round in 2021
MedTrace Pharma A/S, founded in 2015 and based in Kongens Lyngby, Denmark, specializes in the development of innovative solutions for positron emission tomography (PET) imaging. The company has created an automated system, known as MT-100, which efficiently produces and injects 15O-water, a radioactive tracer essential for enhanced imaging. This system is designed to integrate seamlessly with in-house cyclotrons and PET scanners, significantly increasing the sensitivity of patient analysis while improving throughput by up to four times compared to conventional methods. Additionally, MedTrace Pharma develops the aQuant analytical platform, which aids in interpreting PET scan results, further optimizing the diagnostic process. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace is focused on advancing the capabilities of clinical imaging through automation and innovative technology.
1plusX, a TripleLift company
Series B in 2021
At 1plusX, we empower publishers and advertisers to take control of their first-party assets to drive business results. Our real-time data management, data clean room, and CTV solutions converge to help customers engage their audiences with more meaningful and personalized content and advertising. We support publishers in monetizing their inventory and optimize advertisers’ marketing performance through data. So far, we’ve enhanced the marketing performance of companies around the world including Axel Springer, BI Garage, Le Figaro, South China Morning Post, and Tegna. And now part of TripleLift as of March 2022, the advertising technology company reinventing ad placement at the intersection of creative, media and data, we’re bringing publishers and marketers the most viable solution for the privacy-centric era of advertising.
Memo Therapeutics
Series B in 2020
Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.
Varjo Technologies, established in 2016 and based in Helsinki, Finland, specializes in the development of high-fidelity virtual and augmented reality headsets. Its flagship product features a unique bionic display, offering human-eye resolution in the central field of view, surrounded by lower-resolution displays. This design mimics human vision, enhancing immersion and performance in VR and AR experiences. Varjo's customer base includes prominent industry leaders such as Boeing, Lockheed Martin, and Audi, demonstrating the practical applications of its technology in various sectors. The company aims to transform how people work, interact, and play by pioneering metaverse technologies.
Beekeeper
Series B in 2020
Beekeeper is a mobile-first communication platform designed specifically for non-desk employees, facilitating real-time messaging and targeted communication streams across various shifts, locations, and languages. Its application serves as a digital workplace hub, integrating multiple operational systems and communication channels to enhance employee engagement and retention. By automating processes and minimizing dependence on paper, Beekeeper transforms traditional workplace operations, allowing frontline workers to access essential resources such as schedules and paystubs. The platform enables users to communicate instantly, share files, and assign tasks through group chats or predefined streams, all of which can be accessed securely from both desktop and mobile devices. This comprehensive approach empowers clients to improve productivity and effectively connect their teams.
OncoDNA is a theranostic and genomic company that specializes in precision medicine for cancer and genetic diseases. Founded by a team with over 60 years of experience in medical diagnostics, the company focuses on providing clinical guidance for the treatment and real-time monitoring of late-stage cancer patients. OncoDNA supports researchers and biopharma companies in navigating the complexities of molecular biology, facilitating research and drug development in oncology. With its commitment to delivering precision medicine, OncoDNA aims to enhance treatment outcomes and improve the management of cancer and genetic disorders.
Versantis
Series B in 2019
Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, Versantis aims to address significant unmet medical needs for patients globally. Its lead candidate, VS-01, is currently in preclinical development and has the potential to be the first treatment for acute liver disease while simultaneously supporting multiple failing organs. VS-01 has received Orphan Drug Designation for its application in acute liver failure. The company also has additional treatments in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent substantial market opportunities and underscore Versantis' commitment to improving patient outcomes for millions affected by liver conditions and related disorders.
Beekeeper
Series B in 2019
Beekeeper is a mobile-first communication platform designed specifically for non-desk employees, facilitating real-time messaging and targeted communication streams across various shifts, locations, and languages. Its application serves as a digital workplace hub, integrating multiple operational systems and communication channels to enhance employee engagement and retention. By automating processes and minimizing dependence on paper, Beekeeper transforms traditional workplace operations, allowing frontline workers to access essential resources such as schedules and paystubs. The platform enables users to communicate instantly, share files, and assign tasks through group chats or predefined streams, all of which can be accessed securely from both desktop and mobile devices. This comprehensive approach empowers clients to improve productivity and effectively connect their teams.
SWISSto12
Series B in 2019
SWISSto12 SA is a Swiss company that specializes in the manufacture and supply of radio frequency (RF) and microwave components and systems. Founded in 2011 as a spin-off from the Swiss Federal Institute of Technology in Lausanne, the company is based in Renens, Switzerland, with additional offices in Santa Clara, California, and Rehovot, Israel. SWISSto12 offers a range of products including various types of horn antennas, airborne antenna arrays, waveguide antennas, and custom-designed antennas and filters. The company is known for its innovative use of metal-coated 3D printing technology, which enhances design flexibility while reducing costs, lead times, and weight. Its offerings extend to polymer and metal waveguide products, as well as integration and testing services. SWISSto12 serves clients in satellite communications, airborne satellites, and research centers, and is also developing software solutions for material properties extraction.
GetYourGuide
Series E in 2019
GetYourGuide is an online platform that facilitates the booking of tours, attractions, and activities around the globe. Founded in 2009 by Jochen Mattes, Johannes Reck, Martin Sieber, Pascal Mathis, Tao Tao, and Tobias Rein, the platform provides a wide range of services, including tickets to tourist attractions, cooking classes, and various experiential activities. By acting as an intermediary, GetYourGuide allows customers to book these experiences at no direct cost to them; instead, tour providers pay a percentage of their revenue to the platform. This model not only streamlines the booking process for travelers but also includes a customer review system that helps users assess the quality of tour providers. To maintain high standards, GetYourGuide removes consistently poorly reviewed providers from its offerings, ensuring a reliable selection of experiences for users.
GetYourGuide
Secondary Market in 2019
GetYourGuide is an online platform that facilitates the booking of tours, attractions, and activities around the globe. Founded in 2009 by Jochen Mattes, Johannes Reck, Martin Sieber, Pascal Mathis, Tao Tao, and Tobias Rein, the platform provides a wide range of services, including tickets to tourist attractions, cooking classes, and various experiential activities. By acting as an intermediary, GetYourGuide allows customers to book these experiences at no direct cost to them; instead, tour providers pay a percentage of their revenue to the platform. This model not only streamlines the booking process for travelers but also includes a customer review system that helps users assess the quality of tour providers. To maintain high standards, GetYourGuide removes consistently poorly reviewed providers from its offerings, ensuring a reliable selection of experiences for users.